Non-glycaemic benefits of medications for people living with type 2 diabetes
There have been numerous advancements in the pharmacological management of type 2 diabetes (T2D) in recent years. Historically, the foundation of T2D...
Case study: Treatment Induced Neuropathy of Diabetes after rapid improvement in glycaemia following new diagnosis of autoimmune diabetes
Treatment Induced Neuropathy of Diabetes (TIND), also known as insulin neuritis, was first described in...
Consideration of Individual Health Goals During Pharmacotherapy Intensification for Type 2 Diabetes: A Case Study
Optimal glycemic management for those living with type 2 diabetes (T2D) is essential to reduce the risk of macrovascular and microvascular...
Guidelines in 2019 and what they mean for current practice
International1,2 and Australian diabetes Guidelines3,4,5 have been focused on individualisation of diabetes care with risk...